IL112184A0 - Thrombopoietin - Google Patents
ThrombopoietinInfo
- Publication number
- IL112184A0 IL112184A0 IL11218494A IL11218494A IL112184A0 IL 112184 A0 IL112184 A0 IL 112184A0 IL 11218494 A IL11218494 A IL 11218494A IL 11218494 A IL11218494 A IL 11218494A IL 112184 A0 IL112184 A0 IL 112184A0
- Authority
- IL
- Israel
- Prior art keywords
- thrombopoietin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/524—Thrombopoietin, i.e. C-MPL ligand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13933594A IL139335A (en) | 1994-01-03 | 1994-12-29 | Mpl ligand polypeptides, nucleic acids encoding them, vectors and host cells comprising such nucleic acids, processes for producing such polypeptides pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating thrombocytopenia |
IL13933500A IL139335A0 (en) | 1994-01-03 | 2000-10-29 | Thrombopoietin |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17655394A | 1994-01-03 | 1994-01-03 | |
US18560794A | 1994-01-21 | 1994-01-21 | |
US08/196,689 US8357513B1 (en) | 1994-01-03 | 1994-02-15 | Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof |
US22326394A | 1994-04-04 | 1994-04-04 | |
US08/249,376 US8192955B1 (en) | 1994-01-03 | 1994-05-25 | Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof |
US34865894A | 1994-12-02 | 1994-12-02 | |
US08/348,657 US6660256B1 (en) | 1994-01-03 | 1994-12-02 | Porcine mpl ligand |
Publications (2)
Publication Number | Publication Date |
---|---|
IL112184A0 true IL112184A0 (en) | 1995-03-15 |
IL112184A IL112184A (en) | 2004-07-25 |
Family
ID=27569151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11218494A IL112184A (en) | 1994-01-03 | 1994-12-29 | Fusion proteins comprising a mpl ligand and a heterologous polypeptide, nucleic acids encoding such proteins, vectors and host cells comprising such nucleic acid, compositions comprising such fusion proteins and use thereof in the treatment of thrombocytopenia |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP0738323A1 (en) |
JP (2) | JPH09508262A (en) |
CN (1) | CN1134539C (en) |
AU (1) | AU704266B2 (en) |
BG (1) | BG63639B1 (en) |
CA (1) | CA2178482C (en) |
CZ (1) | CZ296130B6 (en) |
DK (1) | DK149194A (en) |
ES (1) | ES2114786B1 (en) |
FI (1) | FI121573B (en) |
FR (1) | FR2714670B1 (en) |
GB (1) | GB2285446B (en) |
HR (1) | HRP941020A2 (en) |
HU (1) | HUT75657A (en) |
IE (1) | IE72517B1 (en) |
IL (1) | IL112184A (en) |
IT (1) | IT1283770B1 (en) |
LU (1) | LU88573A1 (en) |
LV (1) | LV11632B (en) |
NL (1) | NL9500010A (en) |
NO (1) | NO326903B1 (en) |
NZ (1) | NZ278726A (en) |
PT (1) | PT101627B (en) |
RO (1) | RO117110B1 (en) |
SG (1) | SG47030A1 (en) |
SI (1) | SI9420079A (en) |
SK (1) | SK282265B6 (en) |
WO (1) | WO1995018858A1 (en) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6270989B1 (en) * | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
US5733761A (en) | 1991-11-05 | 1998-03-31 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
CA2167090C (en) * | 1994-03-31 | 2002-05-14 | Timothy D. Bartley | Compositions and methods for stimulating megakaryocyte growth and differentiation |
US5795569A (en) * | 1994-03-31 | 1998-08-18 | Amgen Inc. | Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation |
US5986049A (en) * | 1994-12-30 | 1999-11-16 | Zymogenetics, Inc. | Purified thrombopoietin and method of making it |
TW387940B (en) * | 1995-01-17 | 2000-04-21 | Kirin Brewery | Anti-tpo monodonal antibody |
AU4658596A (en) | 1995-02-03 | 1996-08-21 | G.D. Searle & Co. | Novel c-mpl ligands |
CA2209298C (en) * | 1995-02-15 | 2001-12-18 | Amgen Inc. | Mpl ligand analogs |
US5989538A (en) * | 1995-02-15 | 1999-11-23 | Amgen Inc. | Mpl ligand analogs |
US5696250A (en) * | 1995-02-15 | 1997-12-09 | Amgen Inc. | DNA encoding megakaryocyte growth and development factor analogs |
TW434020B (en) * | 1995-03-15 | 2001-05-16 | Kirin Brewery | Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions |
TW434021B (en) * | 1995-03-15 | 2001-05-16 | Kirin Brewery | Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions |
ZA964382B (en) * | 1995-06-06 | 1997-12-01 | Genentech Inc | Lymphotoxin and thrombopoietin for use in the treatment of cancer. |
US5869451A (en) * | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
BR9608587A (en) * | 1995-06-07 | 1999-01-05 | Glaxo Group Ltd | Compound that binds to the thrombopoietin receptor pharmaceutical composition and process for treating a patient suffering from a disorder |
US6251864B1 (en) | 1995-06-07 | 2001-06-26 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
TW497972B (en) * | 1995-06-08 | 2002-08-11 | Kirin Brewery | Stable thrombopoietin (TPO)-containing lyophilized compositions |
US6066318A (en) * | 1995-10-05 | 2000-05-23 | G.D. Searle & Co. | Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors |
US6031071A (en) * | 1996-01-24 | 2000-02-29 | Biophage, Inc. | Methods of generating novel peptides |
US5879673A (en) * | 1996-01-25 | 1999-03-09 | Genentech, Inc. | Administration of thrombopoietin on a single day only |
US7091311B2 (en) | 1996-06-07 | 2006-08-15 | Smithkline Beecham Corporation | Peptides and compounds that bind to a receptor |
CN1230993A (en) * | 1996-08-13 | 1999-10-06 | 津莫吉尼蒂克斯公司 | Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
EP0983082A1 (en) * | 1997-05-21 | 2000-03-08 | Genentech, Inc. | Novel administration of thrombopoietin |
US5980893A (en) * | 1997-07-17 | 1999-11-09 | Beth Israel Deaconess Medical Center, Inc. | Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis |
US6342220B1 (en) | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
KR20000006549A (en) * | 1998-06-30 | 2000-01-25 | 윤재승 | A novel human thrombopoietin mutein |
US20030228666A1 (en) | 1998-06-30 | 2003-12-11 | Daewoong Pharmaceutical Co., Ltd. | Novel human thrombopoietin mutein |
EP1124961B9 (en) | 1998-10-23 | 2010-07-21 | Kirin-Amgen Inc. | Thrombopoietic compounds |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
CY2010012I2 (en) * | 2000-05-25 | 2020-05-29 | Novartis Ag | THROMBOPOIETIN MIMETICS |
UY26317A1 (en) * | 2000-08-30 | 2000-10-31 | Alfonso Cayota Carlos Pritsch | PRODUCTION SYSTEM OF HUMAN THROMBOPOYETINE BY CELLS OF MAMMALS IN CULTIVATION |
US6673580B2 (en) | 2000-10-27 | 2004-01-06 | Genentech, Inc. | Identification and modification of immunodominant epitopes in polypeptides |
US7332474B2 (en) | 2001-10-11 | 2008-02-19 | Amgen Inc. | Peptides and related compounds having thrombopoietic activity |
JP4087338B2 (en) | 2001-11-15 | 2008-05-21 | キリンファーマ株式会社 | Chimeric non-human animal |
KR100467750B1 (en) * | 2001-11-29 | 2005-01-24 | 씨제이 주식회사 | Fusion protein having the enhanced in vivo activity of erythropoietin |
US20030191056A1 (en) | 2002-04-04 | 2003-10-09 | Kenneth Walker | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
WO2004026332A1 (en) | 2002-09-18 | 2004-04-01 | Ortho-Mcneil Pharmaceutical, Inc. | Methods of increasing platelet and hematopoietic stem cell production |
US7723295B2 (en) | 2003-08-28 | 2010-05-25 | Ortho-Mcneil Pharmaceutical, Inc. | Peptides and compounds that bind to a receptor |
CA2537421C (en) | 2003-08-28 | 2011-09-27 | Brian R. Macdonald | Peptides and compounds that bind to thrombopoietin receptor |
EP1751298A4 (en) | 2004-05-18 | 2009-11-11 | Intrexon Corp | Methods for dynamic vector assembly of dna cloning vector plasmids |
US8143380B2 (en) | 2004-07-08 | 2012-03-27 | Amgen Inc. | Therapeutic peptides |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
WO2007102946A2 (en) | 2006-01-23 | 2007-09-13 | Amgen Inc. | Crystalline polypeptides |
WO2007098547A1 (en) * | 2006-03-01 | 2007-09-07 | Apollo Life Sciences Limited | A molecule and chimeric molecules thereof |
US7981425B2 (en) | 2006-06-19 | 2011-07-19 | Amgen Inc. | Thrombopoietic compounds |
CA2658639C (en) | 2006-07-24 | 2015-08-04 | The University Of Queensland | Method of producing a population of cells of the neutrophil lineage |
EP2738257A1 (en) | 2007-05-22 | 2014-06-04 | Amgen Inc. | Compositions and methods for producing bioactive fusion proteins |
EP2390261A4 (en) | 2009-01-20 | 2012-11-14 | Hanall Biopharma Co Ltd | Modified human thrombopoietin polypeptide fragment and manufacturing method thereof |
WO2014089478A1 (en) * | 2012-12-07 | 2014-06-12 | University Of Tennessee Research Foundation | Methods of numerical analysis for platelet disorders and computer-readable media and systems for performing the same |
CN105101979B (en) | 2012-12-21 | 2021-10-08 | 安斯泰来再生医药协会 | Method for preparing platelets from pluripotent stem cells and composition thereof |
CN103555760B (en) * | 2013-10-18 | 2015-05-20 | 江苏康禾生物制药有限公司 | Preparation method and preparation of recombinant human thrombopoietin |
GB201700621D0 (en) | 2017-01-13 | 2017-03-01 | Guest Ryan Dominic | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue |
BR112022005028A2 (en) * | 2019-09-20 | 2022-07-05 | Ractigen Therapeutics | NUCLEIC ACID MOLECULE FOR THROMBOCYTOPENIA TREATMENT AND USE THEREOF |
AU2020408017A1 (en) | 2019-12-20 | 2022-07-14 | Instil Bio (Uk) Limited | Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260417A (en) | 1989-04-03 | 1993-11-09 | Genetics Institute, Inc. | Megakaryocyte growth promoting activity protein |
AU5355790A (en) * | 1989-04-19 | 1990-11-16 | Cetus Corporation | Multifunctional m-csf proteins and genes encoding therefor |
US5223408A (en) * | 1991-07-11 | 1993-06-29 | Genentech, Inc. | Method for making variant secreted proteins with altered properties |
CA2123430C (en) * | 1991-12-06 | 2004-02-10 | Cornelia M. Gorman | Prohormone convertase transformed cells |
IL139335A (en) | 1994-01-03 | 2005-08-31 | Genentech Inc | Mpl ligand polypeptides, nucleic acids encoding them, vectors and host cells comprising such nucleic acids, processes for producing such polypeptides pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating thrombocytopenia |
-
1994
- 1994-12-21 GB GB9425831A patent/GB2285446B/en not_active Expired - Lifetime
- 1994-12-21 SG SG1996003050A patent/SG47030A1/en unknown
- 1994-12-27 HR HR08/348,658A patent/HRP941020A2/en not_active Application Discontinuation
- 1994-12-28 AU AU15146/95A patent/AU704266B2/en not_active Expired
- 1994-12-28 RO RO96-01347A patent/RO117110B1/en unknown
- 1994-12-28 HU HU9601805A patent/HUT75657A/en not_active Application Discontinuation
- 1994-12-28 WO PCT/US1994/014553 patent/WO1995018858A1/en active IP Right Grant
- 1994-12-28 CA CA2178482A patent/CA2178482C/en not_active Expired - Lifetime
- 1994-12-28 SI SI9420079A patent/SI9420079A/en unknown
- 1994-12-28 DK DK149194A patent/DK149194A/en not_active Application Discontinuation
- 1994-12-28 EP EP95906653A patent/EP0738323A1/en not_active Withdrawn
- 1994-12-28 JP JP7518499A patent/JPH09508262A/en active Pending
- 1994-12-28 CN CNB941947513A patent/CN1134539C/en not_active Expired - Lifetime
- 1994-12-28 SK SK875-96A patent/SK282265B6/en not_active IP Right Cessation
- 1994-12-28 CZ CZ0192296A patent/CZ296130B6/en not_active IP Right Cessation
- 1994-12-28 NZ NZ278726A patent/NZ278726A/en not_active IP Right Cessation
- 1994-12-29 IL IL11218494A patent/IL112184A/en not_active IP Right Cessation
- 1994-12-30 ES ES09402681A patent/ES2114786B1/en not_active Expired - Fee Related
- 1994-12-30 PT PT101627A patent/PT101627B/en not_active IP Right Cessation
-
1995
- 1995-01-02 FR FR9500007A patent/FR2714670B1/en not_active Expired - Lifetime
- 1995-01-02 IT IT95TO000002A patent/IT1283770B1/en active IP Right Grant
- 1995-01-03 IE IE950002A patent/IE72517B1/en not_active IP Right Cessation
- 1995-01-03 NL NL9500010A patent/NL9500010A/en active Search and Examination
- 1995-01-03 LU LU88573A patent/LU88573A1/en unknown
-
1996
- 1996-07-02 BG BG100693A patent/BG63639B1/en unknown
- 1996-07-02 NO NO19962783A patent/NO326903B1/en not_active IP Right Cessation
- 1996-07-02 FI FI962723A patent/FI121573B/en not_active IP Right Cessation
- 1996-07-24 LV LVP-96-315A patent/LV11632B/en unknown
-
1997
- 1997-03-27 JP JP9074906A patent/JPH10113186A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2285446B (en) | Thrombopoietin | |
DE59503739D1 (en) | Polymer-sensor | |
DE69502271D1 (en) | Afterabtrennung | |
DE69429543D1 (en) | Koagulationszange | |
DE69504528D1 (en) | Quenchkühler | |
DE59503634D1 (en) | Friercontainer | |
DE59509661D1 (en) | Heterocyclylbenzonitrile | |
ZA9510757B (en) | Restricted 9-cis-retinolds | |
IL139335A0 (en) | Thrombopoietin | |
AU122938S (en) | Breadbox | |
GB9416026D0 (en) | Flexigraze | |
DE69508761D1 (en) | Haloalkylierungsverfahren | |
ZA9410355B (en) | Thrombopoietin | |
DE69506730D1 (en) | Differentialer antriebsmechanismus | |
DE59508136D1 (en) | Phenylthio-oxazolin-derivate | |
DE59510739D1 (en) | N-cyanoaryl-stickstoffheterocyclen | |
DE69502834D1 (en) | Vinylperfluorcyclopropanpolymere | |
DE69504062D1 (en) | Spandexlieferspule | |
DE59503452D1 (en) | Piezoresistiver widerstand | |
ZA941165B (en) | Veroorloofde flodderspringstof | |
GR1002005B (en) | Thrombopoietin. | |
CA73798S (en) | Air-purifier | |
CA73835S (en) | Air-purifier | |
AU124030S (en) | Member | |
GB9402499D0 (en) | Altered abtibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |